| __timestamp | Corcept Therapeutics Incorporated | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 72471000 |
| Thursday, January 1, 2015 | 36949000 | 89204000 |
| Friday, January 1, 2016 | 45240000 | 106010000 |
| Sunday, January 1, 2017 | 62416000 | 137905000 |
| Monday, January 1, 2018 | 81289000 | 159888000 |
| Tuesday, January 1, 2019 | 100359000 | 158425000 |
| Wednesday, January 1, 2020 | 105326000 | 200677000 |
| Friday, January 1, 2021 | 122356000 | 304759000 |
| Saturday, January 1, 2022 | 152848000 | 377221000 |
| Sunday, January 1, 2023 | 184259000 | 336361000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, operational efficiency is key. Over the past decade, Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Corcept's SG&A expenses surged by over 400%, reflecting a strategic expansion and investment in operational capabilities. Meanwhile, Supernus Pharmaceuticals experienced a 360% increase, peaking in 2022, which suggests a robust growth strategy.
By 2023, Supernus's SG&A expenses were nearly double those of Corcept, indicating a more aggressive approach to scaling operations. This comparison not only highlights the differing strategies of these two companies but also underscores the broader industry trend of increasing operational costs. As both companies continue to evolve, their SG&A trajectories will be crucial indicators of their future market positions.
Selling, General, and Administrative Costs: Novartis AG vs Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.